Fluoro-Neplanocin A

Fluoro-Neplanocin A

SCHEMBL9215628

Nc1ncnc2c1ncn2[C@@H]1C(F)=C(CO)[C@@H](O)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHCY P23526 18/20 1.00
ADORA2B P29275 2/20 0.51
DPP4 P27487 1/20 0.51
MEN1 O00255 1/20 0.51
SLC28A1 O00337 1/20 0.51
MAP3K7 O43318 1/20 0.51
SLC28A2 O43868 1/20 0.51
GAPDH P04406 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
MAPK1 P28482 1/20 0.51
ADORA2A P29274 1/20 0.51
ADORA1 P30542 1/20 0.51
STAT6 P42226 1/20 0.51
PI4KA P42356 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PI4K2B Q8TCG2 1/20 0.51
DOT1L Q8TEK3 1/20 0.51
SLC29A1 Q99808 1/20 0.51
PI4K2A Q9BTU6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoro-Neplanocin A SCHEMBL9214735 1.00 AHCY (1.00) AHCYADORA2BDPP4MEN1SLC28A1
Fluoro-Neplanocin A SCHEMBL9214745 1.00 AHCY (1.00) AHCYADORA2BDPP4MEN1SLC28A1
SCHEMBL15390405 0.92 AHCY (1.00) AHCYADORA2BDPP4ADORA3ADORA2A
SCHEMBL863387 0.90 AHCY (0.82) AHCY
SCHEMBL3793061 0.90 AHCY (0.82) AHCY
SCHEMBL863521 0.90 AHCY (1.00) AHCY
SCHEMBL1521121 0.90 AHCY (0.82) AHCY
SCHEMBL10051881 0.89 AHCY (0.84) AHCY
SCHEMBL9216846 0.85 AHCY (1.00) AHCYADORA2BDPP4MEN1SLC28A1
SCHEMBL9214869 0.85 AHCY (1.00) AHCYADORA2BDPP4MEN1SLC28A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014204856-A1 FATTY ACID ANTICANCER DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2014-12-24 WO disclosed
EP-0347852-B1 Novel neplanocin derivatives MERRELL DOW PHARMA (US) 1995-08-23 EP disclosed
EP-0347852-A2 Novel neplanocin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-27 EP disclosed